Global Blood Screening and Typing Markets 2017-2018 & 2019-2023: Opportunities in the Development of Novel Technologies - DNA Sequencing and Microarray Technologies

News provided by

Apr 24, 2019, 19:30 ET

DUBLIN, April 24, 2019 /PRNewswire/ -- The "Blood Screening and Typing: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market.

Growth is primarily driven by the increasing prevalence of chronic and infectious disease like sexually transmitted disease and blood infections. Increases in automation have had a profound impact on the analysis of large sample units of blood with limited errors. New technological products like sequencing and microarrays are expected to propel the growth of the market.

Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user, the market is segmented into hospitals, standalone blood banks, and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East, and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

The Report Includes:

Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types, and consumer groups
Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, the Middle East, and Africa
Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.

Key Topics Covered:

Chapter 1 Introduction

Scope of Report
Inclusions
Exclusions
Information Sources
Methodology
Market Estimation and Forecast
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Key Findings

Chapter 3 Blood Industry Landscape

Overview of Blood
Composition of Blood
Functions of Blood
Classification of Blood Groups
ABO Blood Group
H Antigen
Rhesus System
MNS System
Lutheran System
Kell System
Duffy Antigen System
Kidd Antigen
Blood Collection and Transfusion
Types of Blood Establishments and Blood Facilities
Methods for Collecting Blood from a Donor
Plasma Collection
Blood Transfusions
Types of Transfusions
Complications Associated with Blood Transfusions
Transfusion Transmissible Infections
National Healthcare Safety Network-Biovigilance Component Hemovigilance Module Surveillance
Diseases Contracted from Blood Transfusions and Related Identification Testing
Human Immunodeficiency Virus (HIV)
Epidemiology of Sexually Transmittable Diseases
Blood Screening and Evaluation
Efforts to Create a Virus-Free Blood Supply
Negative Reactions from Blood Transfusions
Blood/Plasma Component Risks
Blood Management Issues
Availability Issues
Bloodless Surgery
Safety Issues: Risk Management
Blood-Transfusion Fatalities

Chapter 4 Market Definition and Dynamics

Definition
Blood Screening
Blood Grouping and Typing
Market Drivers
Increasing Incidence of Chronic Diseases and Infections
Demand for Blood and Blood Transfusion Services
Favorable Safety Regulatory Policies for Blood Products
Increase in Automation
Market Restraints
Government Policies
Price Pressure on Manufacturers
Shortage of Skilled Laboratory Technicians
Emerging Trends and Opportunities
Multiplexing for Blood Screening
Development of Novel Technologies: DNA Sequencing and Microarray Technologies

Chapter 5 Market Segment Analysis

Segment Analysis, by Technology
Immunoassay
Market Size and Forecast
Nucleic Acid Amplification Technology
Polymerase Chain Reaction Amplification
Other Nucleic Acid Amplification Technologies
Market Size and Forecast
Immunohematology (Blood Typing) Techniques
Manual Typing Methods
Automated Blood Typing
Market Size and Forecast
Microbial Techniques
Blood Stream Infections
Blood Cell Culture and Antimicrobial Susceptibility Testing
BioMerieux's VITEK 2 System
Becton, Dickinson and Company's BD Phoenix Identification and Susceptibility Testing System
Market Size and Forecast
Niche Emerging Technologies
DNA Sequencing
Microarray
Market Size and Forecast
Segment Analysis, by End User
Reference Laboratories
Standalone Blood Banks
Hospitals
Segment Analysis, by Blood Type
Donor Blood
Patient Blood

Chapter 6 Market Breakdown by Region

Introduction and Regional Markets
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of the World (RoW)
South America
The Middle East and Africa

Chapter 7 Regulatory and Reimbursement Landscape

Regulations in the United States
Statutory Authority of the FDA
Major Regulations and Policy Matters Concerning the U.S. Blood Supply
Implementation of Regulations
Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood Components
Other Organizations Involved in Blood Regulation
Voluntary Regulation, by Professional and Trade Associations
Reimbursement Landscape in the United States
Preventive Care Services
Regulations in Europe
The International Society for Blood Transfusion: ISBT 128
Regulations in the Asia-Pacific
Regulations in Central and South America
Regulations in the Middle East and Africa

Chapter 8 Market Share Analysis and Recent Industry Developments

Market Share Analysis
Market Share Analysis in the Nucleic Acid Test Segment
Market Share Analysis in the Immunoassay Tests Segment
Market Share Analysis in the Immunohematology Segment
Market Share Analysis in the Microbiology Segment
Recent Industry Developments

Chapter 9 Company Profiles

Abbott Laboratories
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson and Co.
Bio-Rad Laboratories
Biomrieux Sa
Danaher Corp.
Day Medical Sa
Diagast
F. Hoffmann-La Roche Ltd.
Grifols S.A.
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare Gmbh
Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/kjklv2/global_blood?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets